Oxalobacter vibrioformis Details: NCBI 933080, gram-negative or unknown [species]

| DSM 5502| Oxalobacter vibrioformis| Oxalobacter vibrioformis Dehning and Schink 1990| strain WoOx3

  1. Oxalate Metabolism: Oxalobacter vibrioformis is known to metabolize oxalate, converting it into formate and carbon dioxide. This metabolic activity may contribute to the regulation of oxalate levels in the gastrointestinal tract.

  2. Potential Role in Kidney Stone Prevention: Oxalate is a key component of kidney stones. Some studies suggest that Oxalobacter species, including O. formigenes (closely related to O. vibrioformis), may play a role in reducing the risk of kidney stone formation by promoting the breakdown of oxalate in the gut. However, the specific impact of O. vibrioformis in this regard requires further research.

  3. Association with Human Health: The relationship between Oxalobacter species and human health is an area of ongoing research. While some studies suggest a potential association between reduced levels of Oxalobacter and an increased risk of kidney stone formation, the evidence is not conclusive, and more research is needed.

  4. Implications for Oxalate Absorption: Oxalobacter vibrioformis may influence the absorption of dietary oxalate in the intestine, potentially impacting the amount of oxalate that reaches the kidneys. This, in turn, could have implications for individuals prone to kidney stone formation.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Oxalobacter vibrioformis

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.22 1 593 0 638 126.4 13 260.9 1 593 14.3 %ile 71.4 %ile
biomesight 26.15 0 20 20 110 0 189 64.5 40 63.5 0 120 8 %ile 92 %ile
thryve 0.63 1 77 0 84 27.6 19 28.9 1 77 11.1 %ile 77.8 %ile

External Reference Ranges for Oxalobacter vibrioformis

Oxalobacter vibrioformis (NCBI 933080) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Oxalobacter vibrioformis
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 28.061 %   0.006 %  0.006 % 832.0 2965
CerbaLab 66.667 %   0 %  0 % 2.0 3
Medivere 42.857 %   0.021 %  0.033 % 3.0 7
Thryve 0.503 %   0.003 %  0.004 % 7.0 1392

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Food (excluding seasonings) whey 1 Studies recorded. The consensus is Increases📓, Click for details.
Vitamins, Minerals and similar calcium 1 Studies recorded. The consensus is Increases👶, Click for details.
Vitamins, Minerals and similar magnesium 1 Studies recorded. The consensus is Increases👶, Click for details.
Vitamins, Minerals and similar Vitamin C (ascorbic acid) 1 Studies recorded. The consensus is Increases👶, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.